請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/87903完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳俊忠 | zh_TW |
| dc.contributor.advisor | Chun-Chung Chen | en |
| dc.contributor.author | 王主馨 | zh_TW |
| dc.contributor.author | Chu-Hsin Wang | en |
| dc.date.accessioned | 2023-07-31T16:13:19Z | - |
| dc.date.available | 2023-11-09 | - |
| dc.date.copyright | 2023-07-31 | - |
| dc.date.issued | 2023 | - |
| dc.date.submitted | 2023-06-27 | - |
| dc.identifier.citation | 一、中文參考文獻
1. J&J Careers Taiwan (2017)。嬌生的歷史 https://www.facebook.com/watch/?v=1219780174804521 2. J&J (2019)。嬌生商業行為守則 https://www.jnj.com/code-of-business-conduct/chinese-traditional 3. 李吉仁 (2019)。驅動轉型成為轉機 https://www.hbrtaiwan.com/article/18704/four-key-points-for-corporate-transformation 4. 天下雜誌 (2023)。全球消費保健新龍頭赫力昂*(Haleon) 100%致力於提升消費者日常健康 https://www.cw.com.tw/article/5123272 5. 台灣品牌躍飛計畫。不可不知的品牌架構觀念 https://www.branding-taiwan.tw/BrandAnalysis/brandAnalysis_more?id=3f4d322961db4605b9fe4665b7546a24 6. 鉅亨網 (2023)。〈新股IPO〉嬌生消費品業務Kenvue上市首日行情亮麗 盤中股價漲逾20% https://news.cnyes.com/news/id/5165342 7. 104人力銀行 (2023)。壯生醫療器材股份有限公司公司介紹 https://www.104.com.tw/company/7jve00o 二、英文參考文獻 1. Porter, M. E. (1985). Competitive advantage: creating and sustaining superior performance. New York London: Free Press; Collier Macmillan. 2. Arthur A. Thompson Jr. and A. J. Strickland III(1997)Strategic Management: Formulation, Implementation and Control, 6th edition. Reprinted by permission of McGraw-Hill Company, Inc., New York, NY. 3. Kendrick, S. (2012) The TOWS Matrix: Putting a SWOT Analysis into Action. 4. Heinz Weihrich. (1982) The TOWS matrix—A tool for situational analysis 5. Chris Veld and Yulia V. Veld-Merkoulova (2008) Value Creation Through Spin-Offs: A Review of the Empirical Evidence 6. J&J (2023). 2022 Johnson & Johnson Annual Report. https://www.investor.jnj.com/asm/2022-annual-report 7. Market Research. com (2023). Healthcare Services Global Market Briefing 2023 https://www.marketresearch.com/Business-Research-Company-v4006/Healthcare-Services-Global-Briefing-33141045/ 8. Deloitte (2023). 2023 Global Health Care Outlook https://www.deloitte.com/global/en/Industries/life-sciences-health-care/analysis/global-health-care-outlook.html 9. Allied market research (2023). FMCG Global Opportunity Analysis and Industry Forecast 2022-2031 https://www.alliedmarketresearch.com/fmcg-market 10. DAVID PATTERSON (2023). 2023 Fast Moving Consumer Goods Trends https://clarkstonconsulting.com/insights/2023-fmcg-trends/ 11. J&J (2023). J&J Timeline. https://ourstory.jnj.com/timeline 12. J&J (2021). J&J Announcement https://www.jnj.com/johnson-johnson-announces-plans-to-accelerate-innovation-serve-patients-and-consumers-and-unlock-value-through-intent-to-separate-consumer-health-business 13. J&J (2023). Johnson & Johnson Reports Q1 2023 Results https://www.jnj.com/johnson-johnson-reports-q1-2023-results 14. J&J (2023). Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow https://www.jnj.com/johnson-johnson-announces-launch-of-kenvue-inc-ipo-roadshow 15. Hitesh Bhasin (2018). What is TOWS Matrix? https://www.marketing91.com/what-is-tows-matrix/ 16. Tom Gallen (2022). GSK Exits Consumer Health With Haleon Launch https://hbw.pharmaintelligence.informa.com/RS152734/GSK-Exits-Consumer-Health-With-Haleon-Launch 17. Lauren Nardella (2022). Branding For J&J’s Kenvue Cements Consumer Division Separation https://hbw.pharmaintelligence.informa.com/RS152985/Branding-For-JJs-Kenvue-Cements-Consumer-Division-Separation?vid=Pharma 18. Prashanth Reddy, Annie Kurdziel, and Lara Sanfilippo (2019). Transformative healthcare growth through diversification https://www.mckinsey.com/industries/healthcare/our-insights/transformative-healthcare-growth-through-diversification 19. David Ridley (2022). Why Spin Out? IQVIA Consumer Health On The Standalone Trend In OTC https://hbw.pharmaintelligence.informa.com/RS153096/Why-Spin-Out-IQVIA-Consumer-Health-On-The-Standalone-Trend-In-OTC 20. KENVUE (2023). KENVUE Our Story https://www.kenvue.com/our-story | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/87903 | - |
| dc.description.abstract | 近年來醫療保健產業及快速消費品產業皆愈發競爭,而產業內許多醫療保健集團之消費保健品事業體開始拆分為獨立分公司,本研究將以嬌生集團為研究對象,旨在透過深入研究嬌生集團拆分消費品事業為獨立公司 KENVUE 之拆分策略,了解其運籌邏輯,並探討醫療保健業拆分消費品部門之策略意涵。
首先將通過產業分析工具(如:五力分析)分析醫療保健業及快速消費品產業,掌握產業之競爭趨勢,進一步頗析醫療保健集團之消費品事業面臨的挑戰與機會,並聚焦在個案研究對象嬌生集團與 KENVUE ,分析其拆分策略。接著針對拆分後之 KENVUE 公司可能面臨之策略議題包含「品牌經營之挑戰與機會」與「組織變革及企業文化落實子公司之挑戰」分析並提出行動建議。最後,本研究根據研究發現與結論,結合產業及市場趨勢,給予 KENVUE 未來發展的建議。 | zh_TW |
| dc.description.abstract | In recent years, the healthcare and fast-moving consumer goods industries have become increasingly competitive. Many multinational healthcare enterprise groups have begun to spin off their consumer healthcare businesses into independent subsidiaries. This study will focus on the Johnson & Johnson Group, aiming to understand the logic and rationale behind its decision to spin off its consumer healthcare business into an independent company, KENVUE. It will also explore the strategic implications of the healthcare industry's decision to separate its consumer health business.
The study will begin by analyzing the healthcare and fast-moving consumer goods industries using industry analysis tools such as Porter's Five Forces analysis to understand industry trends and further analyze the challenges and opportunities faced by healthcare enterprise groups. The study will then focus on Johnson & Johnson and KENVUE to analyze their spin-off strategy. Next, the study will analyze the strategic issues that KENVUE may face after separation, including challenges and opportunities in brand management and the implementation of corporate culture and organizational change in the subsidiary. The study will conclude by offering recommendations for KENVUE's future development based on research findings, conclusions, and industry and market trends. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-07-31T16:13:19Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2023-07-31T16:13:19Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 誌謝 i
摘要 ii ABSTRACT iii 目錄 iv 圖目錄 vi 表目錄 vii 第一章 緒論 1 第一節 研究背景與動機 1 第二節 研究問題 1 第三節 研究流程 2 第二章 文獻回顧 3 第一節 事業拆分(Spin-off) 3 第二節 五力分析 5 第三節 SWOT分析及應用 6 第四節 企業轉型成長 C-SOP 9 第三章 產業現況 11 第一節 全球醫療保健產業發展現況 11 第二節 全球快速消費品(FMCG)產業發展現況 15 第三節 全球醫療保健產業之消費品事業體發展之挑戰 23 第四章 嬌生集團(J&J)拆分策略分析 28 第一節 嬌生集團(J&J)發展沿革 28 第二節 KENVUE 全球拆分策略與發展挑戰 35 第三節 拆分後台灣子公司品牌經營與挑戰 48 第四節 台灣子公司組織變革及企業文化落實挑戰 55 第五章 結論與建議 61 第一節 研究結論 61 第二節 研究貢獻與管理意涵 62 第三節 研究限制與未來研究方向 63 參考文獻 65 一、中文參考文獻 65 二、英文參考文獻 65 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 拆分策略 | zh_TW |
| dc.subject | KENVUE | zh_TW |
| dc.subject | 嬌生集團 | zh_TW |
| dc.subject | 消費保健事業 | zh_TW |
| dc.subject | C-SOP | zh_TW |
| dc.subject | Johnson & Johnson | en |
| dc.subject | KENVUE | en |
| dc.subject | Consumer Health Business | en |
| dc.subject | Spin-Off Strategy | en |
| dc.subject | C-SOP | en |
| dc.title | 醫療保健產業之消費品事業拆分策略分析—以嬌生集團為例 | zh_TW |
| dc.title | Spin-Off Strategy for the Consumer Goods Business in the Healthcare Industry: Study of Johnson & Johnson | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 111-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 謝明慧;余峻瑜 | zh_TW |
| dc.contributor.oralexamcommittee | Ming-Huei Hsieh;Jiun-Yu Yu | en |
| dc.subject.keyword | 拆分策略,嬌生集團,KENVUE,消費保健事業,C-SOP, | zh_TW |
| dc.subject.keyword | Spin-Off Strategy,Johnson & Johnson,KENVUE,Consumer Health Business,C-SOP, | en |
| dc.relation.page | 67 | - |
| dc.identifier.doi | 10.6342/NTU202301147 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2023-06-28 | - |
| dc.contributor.author-college | 管理學院 | - |
| dc.contributor.author-dept | 國際企業學系 | - |
| 顯示於系所單位: | 國際企業學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-111-2.pdf 未授權公開取用 | 1.87 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
